Use of the Mitotic Counts for the Prognosis and Grading of Breast Cancer
- 1 June 1994
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 190 (6) , 593-599
- https://doi.org/10.1016/s0344-0338(11)80397-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Significance of variation in DNA flow cytoinetric analyses from paraffin-embedded breast cancers: Evaluation of the grading efficiency of ploidy determination, DNA index, and S-phase fractionPathology - Research and Practice, 1992
- DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancerInternational Journal of Cancer, 1992
- Reproducibility of mitosis counting in 2,469 breast cancer specimens: Results from the Multicenter Morphometric Mammary Carcinoma ProjectHuman Pathology, 1992
- The value of mitotic counting in the assessment of prognosis and proliferation in human tumoursThe Journal of Pathology, 1991
- Chapter 22 dentification of Proliferating Cells by Ki-67 AntibodyPublished by Elsevier ,1990
- General Principles of Grading Lesions in Diagnostic HistopathologyPathology - Research and Practice, 1989
- The Flow-Cytometric Analysis of DNA Content and S-Phase Fraction (SPF) of Human Breast CancerPathology - Research and Practice, 1989
- The value of morphometry to classic prognosticators in breast cancerCancer, 1985
- Mitosis counting—A need for reappraisalHuman Pathology, 1981
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957